Daan Gene Co., Ltd.

002030

CNE000001KP1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
6.96 ^CNY	+0.72%		-4.53%	-28.10%

Apr. 29	Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19	MT

Daan Gene Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2021, Payable on May 9, 2022

April 27, 2022 at 03:33 pm EDT

Daan Gene Co., Ltd. proposed final cash dividend per ten shares (tax included) on A shares of CNY 11.10000000 for the year 2021, payable on May 9, 2022. Record date to be May 6, 2022. Ex-date to be May 9, 2022.

Latest news about Daan Gene Co., Ltd.

Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19	Apr. 26	MT
Daan Gene Co., Ltd. Proposes Final Cash Dividend for 2023	Apr. 01	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
MSCI to Add 29 Stocks to Chinese Indices Including JAC Motors, BAIC BluePark, Yutong Bus	23-08-14	MT
Daan Gene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Daan Gene Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 13, 2023	23-06-06	CI
Daan Gene Unit Registers Hepatitis Test Kit	23-05-25	MT
Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Daan Gene Co., Ltd. Approves Cash Dividend for the Year 2022	23-04-21	CI
Daan Gene Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-31	CI
Medical Lab Daan Gene Registers New Nucleic Acid Detection Test	23-03-08	MT
Daan Gene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Chinese COVID testing firms report big profits as virus fight intensifies	22-11-03	RE
Daan Gene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-28	CI
Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Daan Gene Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2021, Payable on May 9, 2022	22-04-27	CI
Daan Gene Co., Ltd. Approves Final Dividend for the Year 2021	22-04-21	CI
Daan Gene Co., Ltd. Proposes Final Cash Dividend for 2021	22-03-31	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Daan Gene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Guangzhou Darui Biotechnology Co., Ltd. announced that it expects to receive CNY 219.999978 million in funding from Daan Gene Co., Ltd., Guangzhou Guochuang Equity Investment Partnership (Limited Partnership)	21-06-29	CI

Chart Daan Gene Co., Ltd.

Duration

Period

More charts

Company Profile

Da An Gene Co., Ltd. specializes in the development, manufacture and marketing of molecular diagnosis products for infectious and epidemic diseases. The group offers real-time polymerase chain reaction instruments (QPCR), immunological products, screening systems for cervical cancer, sequencing tools, blood collection tubes and food safety products.

Sector

Pharmaceuticals

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company